Which action mechanisms are secured in the treatment of radiogenic side effects by hyperbaric oxygenation? Comment on the article by A. Hartmann, M. Almeling, U. M. Carl, Hyperbaric oxygenation (HBO) in the treatment of radiogenic side effects, Strahlenther Onkol l996, 172, 641-8 (No. 12);Welche Wirkmechanismen sind gesichert bei der Behandlung radiogener Nebenwirkungen durch hyperbare Oxygenierung? Zu dem Beitrag von A. Hartmann, M. Almeling, U. M. Carl: Hyperbare Oxygenierung (HBO) zur Behandlung radiogener Nebenwirkungen: Strahlenther Onkol 1996;172:641-8 (Nr. 12).

Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]

Volumn 174, Issue 4, 1998, Pages 221-

  Thilmann, C ^a   Adamietz, I A ^a   Bottcher H D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR;

ANGIOGENESIS; ANIMAL; BONE NECROSIS; CELL CULTURE; HUMAN; HYPERBARIC OXYGEN; LETTER; RADIATION INJURY; RAT;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELLS, CULTURED; HUMANS; HYPERBARIC OXYGENATION; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEORADIONECROSIS; RADIATION INJURIES; RADIATION INJURIES, EXPERIMENTAL; RATS;

MLCS; MLOWN;

EID: 0032044679     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03038532     Document Type: Letter

References (0)